Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引：0
|
作者：
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3507 / 3512
页数：5
相关论文
共 50 条
  • [21] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
    Cortes de Miguel, Sol
    Angel Calleja-Hernandez, Miguel
    Menjon-Beltran, Salomon
    Vallejo-Rodriguez, Inmaculada
    SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 547 - 559
  • [22] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
    Sol Cortés de Miguel
    Miguel Ángel Calleja-Hernández
    Salomón Menjón-Beltrán
    Inmaculada Vallejo-Rodríguez
    Supportive Care in Cancer, 2015, 23 : 547 - 559
  • [23] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    S Kelly
    D Wheatley
    British Journal of Cancer, 2009, 101 : S6 - S10
  • [24] Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
    Kelly, S.
    Wheatley, D.
    BRITISH JOURNAL OF CANCER, 2009, 101 : S6 - S10
  • [25] Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
    Masahiro Kawahira
    Tomoya Yokota
    Satoshi Hamauchi
    Sadayuki Kawai
    Yukio Yoshida
    Yusuke Onozawa
    Takahiro Tsushima
    Akiko Todaka
    Nozomu Machida
    Kentaro Yamazaki
    Akira Fukutomi
    Hirofumi Yasui
    International Journal of Clinical Oncology, 2018, 23 : 1189 - 1195
  • [26] Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
    Kawahira, Masahiro
    Yokota, Tomoya
    Hamauchi, Satoshi
    Kawai, Sadayuki
    Yoshida, Yukio
    Onozawa, Yusuke
    Tsushima, Takahiro
    Todaka, Akiko
    Machida, Nozomu
    Yamazaki, Kentaro
    Fukutomi, Akira
    Yasui, Hirofumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (06) : 1189 - 1195
  • [27] THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHEMOTHERAPY FOR LUNG-CANCER
    SAIJO, N
    EGUCHI, K
    ETOU, H
    MIYACHI, S
    MORINARI, H
    NAKADA, K
    NODA, K
    OHKUNI, Y
    WATANABE, K
    YAMADA, Y
    KABE, J
    KUDO, S
    MANO, K
    MORINARI, H
    TANAKA, T
    UZAWA, T
    OHE, Y
    TAMURA, T
    SASAKI, Y
    SHINKAI, T
    SEMINARS IN ONCOLOGY, 1994, 21 (01) : 54 - 58
  • [28] Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
    Werner Kwasny
    Gabriela Kornek
    Karin Haider
    Julia Valencak
    Herbert Ulrich-Pur
    Melitta Penz
    Friedrich Lang
    Dieter Depisch
    Werner Scheithauer
    Breast Cancer Research and Treatment, 2000, 63 : 235 - 241
  • [29] Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
    Kwasny, W
    Kornek, G
    Haider, K
    Valencak, J
    Ulrich-Pur, H
    Penz, M
    Lang, F
    Depisch, D
    Scheithauer, W
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (03) : 235 - 241
  • [30] The role of granulocyte colony-stimulating factor in breast cancer development: A review
    Liu, Li
    Liu, Yangyang
    Yan, Xiaohua
    Zhou, Chong
    Xiong, Xiangyang
    MOLECULAR MEDICINE REPORTS, 2020, 21 (05) : 2019 - 2029
12345